G-36

G protein-coupled estrogen receptor (GPER), or GPR30, specifically binds natural and man-made estrogens. It is thought to be involved in estrogen-sensitive cancers. GPER knockout mice are fertile, although they exhibit thymic atrophy, impaired glucose tolerance, and altered bone growth. G-36 is a cell-permeable non-steroidal antagonist of GPER, inhibiting activation by either 17beta-estradiol (Cay-10006315) or the GPER-selective agonist G-1 (Cay-10008933) (IC50 = 112 and 165 nM, respectively). It has no detectable binding activity to either ERalpha or ERbeta. G-36 blocks the activation of PI3K or calcium mobilization triggered by estrogen through GPER and it suppresses ERK activation by estrogen or G-1 but not by EGF. G-36 can be used in combination with GPER-selective agonists, like G-1, to distinguish the roles of GPER from those of ERalpha and ERbeta in complex biological systems.Formal Name: (4S)-rel-4-(6-bromo-1,3-benzodioxol-5-yl)-3aR,4,5,9bS-tetrahydro-8-(1-methylethyl)-3H-cyclopenta[c]quinoline. CAS Number: 1392487-51-2. Molecular Formula: C22H22BrNO2. Formula Weight: 412.3. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 30 mg/ml, DMF:PBS (pH 7.2) (1:1): 0.5 mg/ml, DMSO: 20 mg/ml, Ethanol: 1 mg/ml. lambdamax: 206, 243, 293 nm. SMILES: BrC1=CC2=C(OCO2)C=C1[C@@H]3NC(C=CC(C(C)C)=C4)=C4[C@@]5([H])[C@]3([H])CC=C5. InChi Code: InChI=1S/C22H22BrNO2/c1-12(2)13-6-7-19-16(8-13)14-4-3-5-15(14)22(24-19)17-9-20-21(10-18(17)23)26-11-25-20/h3-4,6-10,12,14-15,22,24H,5,11H2,1-2H3/t14-,15+,22-/m1/s1. InChi Key: QTOCPACSSHFGOY-ZCCHDVMBSA-N.